585 related articles for article (PubMed ID: 10099437)
1. Serum-free ex vivo expansion of CD34(+) hematopoietic progenitor cells.
Möbest D; Mertelsmann R; Henschler R
Biotechnol Bioeng; 1998 Nov; 60(3):341-7. PubMed ID: 10099437
[TBL] [Abstract][Full Text] [Related]
2. Ex vivo expansion of enriched peripheral blood CD34+ progenitor cells by stem cell factor, interleukin-1 beta (IL-1 beta), IL-6, IL-3, interferon-gamma, and erythropoietin.
Brugger W; Möcklin W; Heimfeld S; Berenson RJ; Mertelsmann R; Kanz L
Blood; 1993 May; 81(10):2579-84. PubMed ID: 7683923
[TBL] [Abstract][Full Text] [Related]
3. Ex vivo expansion of CD34+ umbilical cord blood cells in a defined serum-free medium (QBSF-60) with early effect cytokines.
Qiu L; Meagher R; Welhausen S; Heye M; Brown R; Herzig RH
J Hematother Stem Cell Res; 1999 Dec; 8(6):609-18. PubMed ID: 10645768
[TBL] [Abstract][Full Text] [Related]
4. Differential kinetics of primitive hematopoietic cells assayed in vitro and in vivo during serum-free suspension culture of CD34+ blood progenitor cells.
Möbest D; Goan SR; Junghahn I; Winkler J; Fichtner I; Hermann M; Becker M; de Lima-Hahn E; Henschler R
Stem Cells; 1999; 17(3):152-61. PubMed ID: 10342558
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor.
Lemoli RM; Fogli M; Fortuna A; Motta MR; Rizzi S; Benini C; Tura S
Exp Hematol; 1993 Dec; 21(13):1668-72. PubMed ID: 7694867
[TBL] [Abstract][Full Text] [Related]
6. Preclinical ex vivo expansion of cord blood hematopoietic stem and progenitor cells: duration of culture; the media, serum supplements, and growth factors used; and engraftment in NOD/SCID mice.
Lam AC; Li K; Zhang XB; Li CK; Fok TF; Chang AM; James AE; Tsang KS; Yuen PM
Transfusion; 2001 Dec; 41(12):1567-76. PubMed ID: 11778074
[TBL] [Abstract][Full Text] [Related]
7. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ
Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
[TBL] [Abstract][Full Text] [Related]
8. The ex vivo expansion capacity of normal human bone marrow cells is dependent on experimental conditions: role of the cell concentration, serum and CD34+ cell selection in stroma-free cultures.
Poloni A; Giarratana MC; Firat H; Kobari L; Gorin NC; Douay L
Hematol Cell Ther; 1997 Apr; 39(2):49-58. PubMed ID: 9168300
[TBL] [Abstract][Full Text] [Related]
9. Stem cell factor (c-kit ligand) enhances the interleukin-9-dependent proliferation of human CD34+ and CD34+CD33-DR- cells.
Lemoli RM; Fortuna A; Fogli M; Motta MR; Rizzi S; Benini C; Tura S
Exp Hematol; 1994 Aug; 22(9):919-23. PubMed ID: 7520394
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-beta 1 delays formation of granulocyte-macrophage colony-forming cells, but spares more primitive progenitors during ex vivo expansion of CD34+ haemopoietic progenitor cells.
Garbe A; Spyridonidis A; Möbest D; Schmoor C; Mertelsmann R; Henschler R
Br J Haematol; 1997 Dec; 99(4):951-8. PubMed ID: 9432049
[TBL] [Abstract][Full Text] [Related]
11. Maintenance of transplantation potential in ex vivo expanded CD34(+)-selected human peripheral blood progenitor cells.
Henschler R; Brugger W; Luft T; Frey T; Mertelsmann R; Kanz L
Blood; 1994 Nov; 84(9):2898-903. PubMed ID: 7524757
[TBL] [Abstract][Full Text] [Related]
12. Stromal factors support the expansion of the whole hemopoietic spectrum from bone marrow CD34+DR- cells and of some hemopoietic subsets from CD34+ and CD34+DR+ cells.
Herman P; Ferrant A; De Bruyère M; Straetmans N
Leukemia; 1998 May; 12(5):735-45. PubMed ID: 9593272
[TBL] [Abstract][Full Text] [Related]
13. Production of functional myeloid cells from CD34-selected hematopoietic progenitor cells using a clinically relevant ex vivo expansion system.
Lill MC; Lynch M; Fraser JK; Chung GY; Schiller G; Glaspy JA; Souza L; Baldwin GC; Gasson JC
Stem Cells; 1994 Nov; 12(6):626-37. PubMed ID: 7533581
[TBL] [Abstract][Full Text] [Related]
14. Animal serum-free culture of purified human CD34+ cells: amplification of progenitors from G-CSF and GM-CSF-mobilized peripheral blood.
Schain LR; Jain S; Wysocki M; Hall M; Dadey B; Pennathur-Das R; Biddle W; Wolf J; Okarma TB; Lebkowski JS
J Hematother; 1997 Aug; 6(4):335-49. PubMed ID: 9377072
[TBL] [Abstract][Full Text] [Related]
15. Effective ex vivo generation of granulopoietic postprogenitor cells from mobilized peripheral blood CD34(+) cells.
Scheding S; Meister B; Bühring HJ; Baum CM; Mc Kearn JP; Bock T; Kanz L; Brugger W
Exp Hematol; 2000 Apr; 28(4):460-70. PubMed ID: 10781904
[TBL] [Abstract][Full Text] [Related]
16. A stromal-free, serum-free system to expand ex vivo hematopoietic stem cells from mobilized peripheral blood of patients with hematologic malignancies and healthy donors.
Yao CL; Hsu SC; Hwang SM; Lee WC; Chiou TJ
Cytotherapy; 2013 Sep; 15(9):1126-35. PubMed ID: 23768928
[TBL] [Abstract][Full Text] [Related]
17. Long-term culture-initiating cell expansion is dependent on frequent medium exchange combined with stromal and other accessory cell effects.
Koller MR; Palsson MA; Manchel I; Palsson BO
Blood; 1995 Sep; 86(5):1784-93. PubMed ID: 7544642
[TBL] [Abstract][Full Text] [Related]
18. Ex vivo expansion of CD34+ peripheral blood progenitor cells: implications for the expansion of contaminating epithelial tumor cells.
Vogel W; Behringer D; Scheding S; Kanz L; Brugger W
Blood; 1996 Oct; 88(7):2707-13. PubMed ID: 8839866
[TBL] [Abstract][Full Text] [Related]
19. Expansion of mobilized peripheral blood progenitor cells under defined culture conditions rsing CD34+CD71-CD45- cells as a starting population.
Zech NH; Gunsilius E; Clausen J; Hoflehner E; Hoelzler K; Gastl G; Petzer AL
J Hematother Stem Cell Res; 2003 Aug; 12(4):367-73. PubMed ID: 12965074
[TBL] [Abstract][Full Text] [Related]
20. Platelet released growth factors boost expansion of bone marrow derived CD34(+) and CD133(+) endothelial progenitor cells for autologous grafting.
Lippross S; Loibl M; Hoppe S; Meury T; Benneker L; Alini M; Verrier S
Platelets; 2011; 22(6):422-32. PubMed ID: 21473675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
